Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 09, 2017 16:15 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports Second Quarter 2017 Financial Results

MEDFORD, N.Y., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today reported financial results...
August 03, 2017 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio to Host Conference Call to Discuss Second Quarter 2017 Financial Results

MEDFORD, N.Y., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ:CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, announced today that it...
July 06, 2017 08:50 ET | Source: Chembio Diagnostics, Inc.

Gail S. Page Joins Chembio Diagnostics Board of Directors

MEDFORD, N.Y., July 06, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that Gail S. Page...
July 05, 2017 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio’s DPP® Zika System Including the DPP® Micro Reader Approved by Brazil’s Health Regulatory Agency

MEDFORD, N.Y., July 05, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has...
June 27, 2017 16:30 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Announces At-The-Market Program

MEDFORD, N.Y., June 27, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has...
May 09, 2017 16:10 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports First Quarter 2017 Financial Results

MEDFORD, N.Y., May 09, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today reported financial results...
May 03, 2017 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio Secures $5.8 Million Bio-Manguinhos Order to Supply Components for Production of DPP® HIV 1/2 Assay in Brazil

MEDFORD, N.Y., May 03, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has secured...
May 02, 2017 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio to Host Conference Call to Discuss First Quarter 2017 Financial Results

MEDFORD, N.Y., May 02, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ:CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, announced today that it...
April 04, 2017 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio and FIND Collaborate to Develop Point-of-Care Multiplex Test for Acute Febrile Illnesses in Asia Pacific

MEDFORD, N.Y and GENEVA, April 04, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, is collaborating with...
March 07, 2017 16:10 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports 2016 Financial Results

MEDFORD, N.Y., March 07, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (“POC”) diagnostic tests for infectious diseases, today reported financial...